InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
0.9399
+0.0169 (1.83%)
Feb 2, 2026, 11:51 AM EST - Market open
InterCure Market Cap
InterCure has a market cap or net worth of $51.62 million as of February 2, 2026. Its market cap has decreased by -31.05% in one year.
Market Cap
51.62M
Enterprise Value
93.21M
1-Year Change
-31.05%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.78M to $51.62M, an increase of 2,797.88%. That is a compound annual growth rate of 24.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 51.62M | -7.00% |
| Dec 31, 2025 | 55.50M | -25.61% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardiol Therapeutics | 104.69M |
| Citius Oncology | 93.57M |
| Assertio Holdings | 75.59M |
| Cumberland Pharmaceuticals | 56.09M |
| Zhengye Biotechnology Holding | 46.36M |
| Talphera | 44.56M |
| Rockwell Medical | 42.16M |
| BioXcel Therapeutics | 34.77M |